Cancer Genetics Estimates Preliminary Q2 Revenues of $1.7M to $1.8M | GenomeWeb

NEW YORK (GenomeWeb News) — Cancer Genetics today said in a regulatory document that its second-quarter revenues are expected to be in the range of $1.7 million and $1.8 million.

That compares to $1.1 million in the second quarter of 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.